![2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/de27ccdf-71f2-489b-9232-52728c2dd131/cir.0000000000000923.tab40.gif)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation
![Alignment and divergence in European and North American aortic stenosis guidelines - EuroIntervention Alignment and divergence in European and North American aortic stenosis guidelines - EuroIntervention](https://files.eurointervention.com/issues/EIJ201e/190_EIJ-E-21-00013_Otto_201/image/01_Otto_201e.jpg)
Alignment and divergence in European and North American aortic stenosis guidelines - EuroIntervention
![2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/80c089f3-c197-4f1a-aaad-2b76740bb502/cir.0000000000000923.tab08.gif)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation
![Table 1: Current Recommendations for Anti-Platelet and Anti-thrombotic Therapy Following TAVI | Radcliffe Cardiology Table 1: Current Recommendations for Anti-Platelet and Anti-thrombotic Therapy Following TAVI | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/table1-current-recommendations-for-anti-platelet.png)
Table 1: Current Recommendations for Anti-Platelet and Anti-thrombotic Therapy Following TAVI | Radcliffe Cardiology
![2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/43b13ebb-be07-4fc3-a943-d21968990500/cir.0000000000000923.tab16.gif)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation
Pascal Meier,MD on Twitter: "The NEW 2021 ESC Guidelines for Valvular Heart Disease #ESCcongress #ESCGuidelines -> Upgraded indications for most transcatheter valve interventions -TAVI -Mitral edge-to-edge repair (TEER) -Tricuspid valve ...
![CM Otto on Twitter: "Choice of TAVI versus SAVR when AVR needed for severe AS. In 2020 AHA/ACC Guidelines released today, a key concept is balance of expected longevity versus valve durability. CM Otto on Twitter: "Choice of TAVI versus SAVR when AVR needed for severe AS. In 2020 AHA/ACC Guidelines released today, a key concept is balance of expected longevity versus valve durability.](https://pbs.twimg.com/media/Epe0X9MXIAIl5jH.jpg)